subcutaneous

puzzle pieces merger and acquisition business concept
Favicon Fierce Pharma

Halozyme buys Elektrofi for up to $900M

The deal will give Halozyme a subcutaneous drug delivery technology that has attracted the likes of argenx, Eli Lilly and Jonson & Johnson.
Angus Liu Oct 1, 2025 2:36pm
Astellas US

Astellas taps ReForm to improve clinical-phase biologics

Mar 5, 2019 9:39am
Bristol-Myers

Bristol-Myers pays Halozyme $105M to access I-O delivery tech

Sep 14, 2017 6:59am
Boxing Gloves

Omeros defends drug data, vows to unmask short seller

Aug 24, 2017 9:52am